Title: Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice.
Journal: Pharmacology, biochemistry, and behavior 20111001
Title: Synthesis and pharmacological evaluation of bivalent antagonists of the nociceptin opioid receptor.
Journal: European journal of medicinal chemistry 20110401
Title: Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.
Journal: British journal of pharmacology 20090701
Title: Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats.
Journal: Pharmacology, biochemistry, and behavior 20090501
Title: Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice.
Journal: Journal of anesthesia 20090101
Title: Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.
Journal: Neuropeptides 20080601
Title: [Prostaglandin and nociceptin/orphanin FQ].
Journal: Masui. The Japanese journal of anesthesiology 20071101
Title: NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
Journal: Neuropeptides 20070801
Title: The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
Journal: The European journal of neuroscience 20060201
Title: Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation.
Journal: European journal of pharmacology 20050314
Title: A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists.
Journal: European journal of medicinal chemistry 20041201
Title: Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model.
Journal: Neuroscience letters 20031120
Title: Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production.
Journal: The European journal of neuroscience 20030401
Title: Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
Journal: The Journal of pharmacology and experimental therapeutics 20021001
Title: Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801.
Journal: British journal of pharmacology 20020101
Title: 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.
Journal: Journal of medicinal chemistry 20001130
Title: Yamada H, et al. Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801. Br J Pharmacol, 2002, 135(2), 323-332.
Title: Koyama T, et al. Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice. J Anesth. 2009;23(2):301-3.
Title: Shinkai H, et al. 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity. J Med Chem, 2000, 43(24), 4667-4677.
Title: Zhang Y, et al. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol. 2015 Jan;172(2):571-82.